Andrea Chassot

Andrea Chassot (Agostinho), MD, currently serves as the External Innovation Lead and Head of Medical for Early Clinical Development in pRED Oncology at Roche, where leadership is provided to a team of 13 physician scientists in developing and executing clinical development plans for early oncology studies. Prior experience includes a role as Executive Director and Global Program Clinical Head for lung cancer assets at Novartis, along with a Senior Clinical Development Medical Director position focusing on CAR-T programs. Andrea Chassot also held various positions at Bayer Pharmaceuticals, contributing as Medical Director and Study Medical Expert in oncology. Earlier experience includes roles in pediatric oncology at Gustave Roussy and Gop - Grupo De Oncologia Pediatrica S/C Ltda. Educational qualifications encompass an MD from Universidade Estadual Paulista Júlio de Mesquita Filho and advanced studies in executive leadership and international relations from institutions such as Cornell University and The London School of Economics.